Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Adicionar filtros








Intervalo de ano
1.
Indian J Exp Biol ; 2002 Mar; 40(3): 349-51
Artigo em Inglês | IMSEAR | ID: sea-57614

RESUMO

Nitric oxide inhibitor L-NAME when given alone caused a significant rise in both systolic and diastolic pressure, an increase in 24 hr urinary protein excretion and reduction in weight of the litter as compared to control group. Supplementation of MgSO4 at lower dose (250 mg/kg) did not inhibit this pre-eclamptic effect of L-NAME; but in higher doses (500 and 750 mg/kg), it inhibited the pre-eclamptic action of L-NAME. The results suggest that administration of MgSO4 improves the foetal outcome and significantly prevents the development of symptoms of pre-eclampsia like hypertension and proteinuria.


Assuntos
Administração Oral , Animais , Pressão Sanguínea/efeitos dos fármacos , Inibidores Enzimáticos/toxicidade , Feminino , Sulfato de Magnésio/administração & dosagem , NG-Nitroarginina Metil Éster/toxicidade , Óxido Nítrico Sintase/antagonistas & inibidores , Pré-Eclâmpsia/fisiopatologia , Gravidez , Proteinúria/prevenção & controle , Ratos , Ratos Wistar
3.
Indian J Physiol Pharmacol ; 2001 Jan; 45(1): 107-10
Artigo em Inglês | IMSEAR | ID: sea-107607

RESUMO

Substantial evidence has accumulated that spinally projecting serotonergic neurons modulate nociception. However, the exact receptor subtypes that mediate the antinociceptive response of serotonin within the spinal cord continue to be a subject of debate. Therefore, we explored the effect of serotonergic system on imipramine induced antinociception by using 5-Hydroxytryptamine-3 (5HT3) receptor antagonist ondansetron and 5-Hydroxytryptamine-2 (5HT2) receptor antagonist mianserine, and depletion of brain 5-Hydroxytryptamine (5HT) with p-chlorophenyl alanine (PCPA). Male wistar strain rats were pretreated with either ondansetron (0.5 mg/kg, i.p.) or mianserine (1 mg/kg, i.p.). After 15 minutes, rats received injection of imipramine (10 mg/kg). Nociception was assessed by tail-flick method. Imipramine (2 mg, 5 mg, 10 mg, and 20 mg/kg) produce antinociceptive response in the dose dependent manner. Prior treatment with 5HT3 antagonist, Ondansetron and 5HT2 antagonist, mianserine reduce the antinociceptive response of imipramine. In PCPA treated rats imipramine (10 mg/kg) failed to produce antinociception. These results indicate that the 5HT plays an important role in imipramine induced antinociception.


Assuntos
Inibidores da Captação Adrenérgica/farmacologia , Animais , Fenclonina/farmacologia , Imipramina/farmacologia , Masculino , Mianserina/farmacologia , Ondansetron/farmacologia , Medição da Dor/efeitos dos fármacos , Ratos , Ratos Wistar , Receptores de Serotonina/efeitos dos fármacos , Receptores 5-HT3 de Serotonina , Serotonina/metabolismo , Antagonistas da Serotonina/farmacologia
4.
Indian J Physiol Pharmacol ; 2000 Oct; 44(4): 449-55
Artigo em Inglês | IMSEAR | ID: sea-108734

RESUMO

Nimodipine, a dihydropyridine calcium channel blocker, was administered orally using two different doses (40 mg and 60 mg/kg/day) to rats. Both short term (2 weeks) and long term (6 weeks) effects of the drug were observed. The drug administration resulted in a marked decrease in sperm density, sperm motility and acrozomal reaction. Zona-pellucida penetration by the sperm obtained from drug-treated animals was significantly lower when compared with sperm from normal animals. Nimodipine stimulated Ca2+ ATPase activity in isolated plasma membrane of rate spermatozoa. In conclusion, short term and long term administration of nimodipine has deleterious effect on male reproductive functions in rats.


Assuntos
Reação Acrossômica/efeitos dos fármacos , Animais , Bloqueadores dos Canais de Cálcio/farmacologia , ATPases Transportadoras de Cálcio/efeitos dos fármacos , Feminino , Masculino , Nimodipina/farmacologia , Ratos , Reprodução/efeitos dos fármacos , Contagem de Espermatozoides , Motilidade dos Espermatozoides/efeitos dos fármacos , Zona Pelúcida/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA